Sr. Director Regulatory Affairs
Johnson & Johnson MedTech, Vision
Rosanne is the Head of Regulatory Affairs for Mature Eye products at Johnson & Johnson Vision. She is responsible for leading a global regulatory affairs team for new product introduction and life cycle management of medical devices including cataract extraction systems and intraocular lenses, as well as ophthalmic viscosurgical devices (OVDs) and insertion systems.
She began her career in a hybrid Regulatory Affairs and Research Scientist role with Abbott. Since then, she has assumed roles of increasing responsibility and is now the head of the department responsible for global regulatory approvals and life cycle management for the largest business franchise for J&J Surgical Vision. She has also developed key talent within the regulatory affairs organization, supported critical business development projects and has actively participated in U.S and international device standards meetings. Rosanne often presents to Health Authorities including the FDA, Health Canada, and DEKRA (EU) on novel implantable lens technologies and clinical trials.
Rosanne received her PhD in Genetics, Molecular, and Cellular Biology from USC’s Keck School of Medicine where she studied genetic models for retinal degeneration. She simultaneously completed a Master’s Degree in Regulatory Science and a Certificate in Clinical Study Design and Management from the USC School of Pharmacy.
Rosanne Melikian has published peer-reviewed scientific manuscripts in vision research and co-authored articles in the regulatory affairs professional journal, FOCUS, including an article on Mergers and Acquisitions in the Healthcare Product Industry. Rosanne received her Regulatory Affairs Certification in US regulations and has received numerous industry leadership awards. In 2020, Rosanne was selected as a member of the inaugural class of Ophthalmic World Leaders (OWL) Fellows where she collaborated with business leaders in the Ophthalmology industry.
Rosanne is driven by bringing innovative medical products to patients around the world and developing creative approaches to problem solving.
Monday, September 16, 2024
8:30 AM – 4:00 PM PDT